by Alex Watkins ONeill | Mar 31, 2026 | Content
The American Medical Association’s 2025 Report on Substance Use and Treatment notes a decline in overdose deaths while also underscoring the continued complexity of the epidemic amid rising polysubstance use and an increasingly unpredictable illicit drug supply. The...
by Alex Watkins ONeill | Mar 24, 2026 | Content
A massive global genetics study is reshaping how we understand mental illness and why diagnoses so often pile up. By analyzing genetic data from more than six million people, researchers uncovered deep genetic connections across 14 psychiatric conditions, showing that...
by Alex Watkins ONeill | Mar 17, 2026 | Content
The regulatory landscape for substance use disorder (SUD) treatment records is changing—and the impact will extend far beyond traditional addiction treatment programs. With treatment options for SUD limited, some providers are exploring ketamine as a potential therapy...
by Alex Watkins ONeill | Mar 10, 2026 | Content
On any given day in a busy primary care clinic, doctors and others often ask patients about their alcohol use, and try to gauge if it falls into healthy or problematic range. Patients might even complete an alcohol use questionnaire on a clipboard or their smartphone...
by Alex Watkins ONeill | Mar 3, 2026 | Content
On December 30, 2025, the Federal Register indicated that the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) are jointly issuing a fourth temporary extension rule (the “Fourth Temporary Extension Rule”), preserving existing...
by Alex Watkins ONeill | Feb 24, 2026 | Content
During 2025, the Knox County Regional Forensic Center identified a new synthetic opioid in three East Tennessee counties. While limited information is available on the new substance, here is what is known about N-Propionitrile Chlorphine, which is also known by the...
Recent Comments